BAC
Bank of America Corporation
BAC has the edge over OPY overall, supported by stronger valuation and stronger fundamentals.
OPY
Oppenheimer Holdings Inc.
OPY trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
OPY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
OPY's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like OPY.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over OPY in the historical PE scenario, which offers more potential upside but is not a forecast.
OPY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.1x | $30.75 | -66% |
| Fair | 9x | $66.53 | -26% |
| Current | 12x | $89.68 | — |
| Expensive | 13x | $93.25 | +4% |
Historical ranges are pointers, not guarantees.
OPY's PE is in its expensive range at 12x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
OPY Forward outlook
There aren't enough analyst estimates for OPY to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
OPY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $7.43 | -0.3% |
| Q2 2026 | $8.86 | +15% |
| Q1 2026 | $8.39 | +25% |
| Q4 2025 | $13.04 | +105% |
| Q3 2025 | $7.45 | +15% |
| Q2 2025 | $7.71 | +40% |
| Q1 2025 | $6.72 | +80% |
| Q4 2024 | $6.37 | +146% |
OPY's earnings per share have fallen from their peak: $7.43 over the past year, against $13.28 in late 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over OPY on profitability, with a higher operating margin.
OPY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $382M | -10% |
| Q2 2026 | $454.9M | +22% |
| Q1 2026 | $445.1M | +21% |
| Q4 2025 | $472.6M | +26% |
| Q3 2025 | $424.4M | +14% |
| Q2 2025 | $373.2M | +13% |
| Q1 2025 | $367.8M | +4.2% |
| Q4 2024 | $375.4M | +22% |
OPY's revenue is growing: $382M last quarter, down 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.3% | -5.2 points |
| Q2 2026 | 8.7% | 0 points |
| Q1 2026 | -6.1% | -17 points |
| Q4 2025 | 22% | +18 points |
| Q3 2025 | 7.5% | -2 points |
| Q2 2025 | 8.6% | +3.8 points |
| Q1 2025 | 11% | +0.6 points |
| Q4 2024 | 4.5% | -1.2 points |
OPY's operating margin was 2.3% last quarter, down 5.2 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
OPY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $128.6M | +107% |
| Q2 2026 | -$57.1M | -247% |
| Q1 2026 | -$190M | -$96.6M |
| Q4 2025 | $175.8M | +146% |
| Q3 2025 | $62.2M | +455% |
| Q2 2025 | $38.9M | +$155.6M |
| Q1 2025 | -$93.4M | -$14.1M |
| Q4 2024 | $71.5M | +17% |
OPY has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over OPY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
OPY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +103K shares |
| 1 year | +1.2% | +136K shares |
| 3 years | +1.3% | +146K shares |
| 5 years | -15% | -2.1M shares |
| Available history | -16% | -2.3M shares |
OPY has 12M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $2.3M |
| Q3 2025 | — |
| Q2 2025 | $581,000 |
| Q1 2025 | $90,000 |
| Q4 2024 | — |
OPY spent $2M buying back its own shares over the past year, about three times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
OPY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 1.5x | Healthy |
| Q3 2023 | 1.2x | Healthy |
| Q2 2023 | 1.6x | Healthy |
| Q1 2023 | 1.4x | Healthy |
| Q4 2022 | 0.0x | Very low |
| Q3 2022 | 0.8x | Very low |
| Q2 2022 | 0.6x | Very low |
| Q1 2022 | 0.4x | Very low |
OPY's net debt is about 1.5 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like OPY.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
OPY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 14.4 | Oversold |
OPY's weekly RSI is 39 (neutral) and its Stochastic is 14 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over OPY on valuation relative to its sector.
OPY PE vs Financial Services Sector
| Metric | OPY | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.3% below |
| PE % | 80 | 63 | 17 pts above |
OPY is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
OPY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $102.8 | 13% below |
| 20 week MA | $109.8 | 18% below |
| 50 week MA | $97.5 | 8.1% below |
| 100 week MA | $82.0 | 9.4% above |
| 200 week MA | $62.7 | 43% above |
OPY has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
OPY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.8 | $31.7 | +14% |
| 2021 | $31.7 | $44.2 | +39% |
| 2022 | $44.2 | $42.8 | -3.2% |
| 2023 | $42.8 | $41.3 | -3.4% |
| 2024 | $41.3 | $64.5 | +56% |
| 2025 | $64.5 | $74.2 | +15% |
| 2026 YTD | $74.2 | $89.7 | +21% |
OPY has the edge over BAC on returns for 2026, with the stronger performance.